Sign In

Sareum Holdings plc

Sareum is a specialist protein structure-based drug discovery company. Sareum supports its ongoing drug discovery of novel oncology therapeutics by the provision of quality discovery research programs and services. These are based on Sareum's advanced integrated & automated platforms for protein structure-based lead generation and optimisation, protein structure determination and automated medicinal chemistry

• Show past press releases
• Edit this company

Elevator Pitch
Sareum is a highly experienced team with key expertise gained from a wide range of pharmaceutical and discovery-service companies. Key drug discovery technologies include Template Screening lead identification and Crystal Bank protein structure resource. The company provides quality research programs and services with flexible deal terms, ranging from product licencing to fee-for-service. Sareum has been listed on the AIM market of the London Stock Exchange since October 2004.

Contact Information
2, Pampisford Park
Cambridge CB2 4EE
United Kingdom
+44 (0)1223 497 700
+44 (0)1223 497 701
Tim Mitchell
+44 (0)1223 497 700

Company Facts
Founded:Aug 2003
Founders:Dr Tim Mitchell, Dr John Reader, Dr David Williams
CEO:Dr Tim Mitchell
CTO or technical lead:
CFO or finance director:
Head of Sales:Mr Martin Gouldstone
Head of Marketing:

Category:Biotechnology & Healthcare
Profitability:Not Profitable
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:Yes

Non-executive Board Members

  • Dr Paul Harper, Chairman, Angel Biotechnology
  • Dr Alan Lamont, VP, Business Development, Acambis

    Key Customers

  • Genentech, Inc
  • Roche
  • Indenix Pharmaceuticals, Inc
  • Organon
  • Schering AG

    Key Business Partners

  • The Institute of Cancer Research
  • Cancer Research Technologies Ltd

    Key Competitors

    Capital Raised
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    Oct 2004InitialLondon Stock Exchange, AIM

  • Data

    Tech investments
    From our Online Data Service
    VC-backed companies
    From our Radar

    Recent Deals

    Nov 25€24.0MInternet commerce
    Mar 23€2.0MInternet services
    Mar 23€1.5MInternet services
    Mar 23€110.0MInternet commerce
    Mar 21€1.9MBusiness applications
    Mar 20€1.0MInternet commerce
    Mar 20€12.0ME-Commerce

    For information on Europe's most extensive database on technology funding click here!


    Press Releases

    May 28
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    nethone raised over $1 million from innovation nest

    Jan 29
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.